OR WAIT null SECS
January 24, 2022
Funding brings total investment to $123 million.
January 20, 2022
Indegene’s 2021–22 survey on the digital habits of HCPs across major regions provides some answers to pharma marketers looking to boost their post-pandemic physician engagement campaigns.
January 18, 2022
Investigational New Drug application accepted for natural killer cell therapy.
January 14, 2022
Pharma R&D return on investment rises to highest level since 2014.
January 13, 2022
January 12, 2022
Ashfield Engage and ysura announce partnership to transform HCP and pharma interactions through a superior customer experience
In a highly unusual decision for a therapy approved by FDA, CMS has taken action to limit prescribing and use of Biogen’s new and controversial Alzheimer’s treatment Aduhelm.
January 07, 2022
Indegene’s Kay Uttech won the “Engagement Achievement Award” by the Healthcare Businesswomen’s Association (HBA) for her contribution for promoting gender parity in the industry in 2021.
Sameer Rabbani talks to Pharm Exec about the new initiative from GSK Consumer Healthcare’s Theraflu to provide relief for those facing access barriers to sick time and raise awareness of the cultural stigma associated with taking a sick day.
